Aequus Pharmaceuticals (AQSZF) is a growing specialty pharmaceutical company with an increasing pipeline of commercial products in ophthalmology and transplant, and a development stage pipeline in neurology and psychiatry. In today's article I will follow-up on my latest article from 29th August 2019 and will summarize the progress in order to verify the investment opportunity.
Recap of Investment Opportunity
My thesis of the investment opportunity is based on projected revenue growth coming from already marketed products and new in-licensed products, creating an opportunity to reach breakeven in 2020. Considering the very small market-cap